These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 26611146)
21. The identification of immune genes in the milk transcriptome of the Tasmanian devil (Sarcophilus harrisii). Hewavisenti RV; Morris KM; O'Meally D; Cheng Y; Papenfuss AT; Belov K PeerJ; 2016; 4():e1569. PubMed ID: 26793426 [TBL] [Abstract][Full Text] [Related]
22. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil. Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301 [TBL] [Abstract][Full Text] [Related]
23. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils. Deakin JE; Belov K Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390 [TBL] [Abstract][Full Text] [Related]
24. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil. Hollings T; Jones M; Mooney N; McCallum H Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987 [TBL] [Abstract][Full Text] [Related]
25. Does the devil facial tumour produce immunosuppressive cytokines as an immune evasion strategy? Morris K; Belov K Vet Immunol Immunopathol; 2013 May; 153(1-2):159-64. PubMed ID: 23465357 [TBL] [Abstract][Full Text] [Related]
26. Characterisation of non-classical MHC class I genes in the Tasmanian devil (Sarcophilus harrisii). Cheng Y; Belov K Immunogenetics; 2014 Dec; 66(12):727-35. PubMed ID: 25267059 [TBL] [Abstract][Full Text] [Related]
27. Expansion of CORE-SINEs in the genome of the Tasmanian devil. Nilsson MA; Janke A; Murchison EP; Ning Z; Hallström BM BMC Genomics; 2012 May; 13():172. PubMed ID: 22559330 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii). Jones EA; Cheng Y; O'Meally D; Belov K Immunogenetics; 2017 Mar; 69(3):133-143. PubMed ID: 27838759 [TBL] [Abstract][Full Text] [Related]
29. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response. Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167 [TBL] [Abstract][Full Text] [Related]
30. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil ( Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909 [TBL] [Abstract][Full Text] [Related]
31. Reduced effect of Tasmanian devil facial tumor disease at the disease front. Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020 [TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil. Bender HS; Marshall Graves JA; Deakin JE Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139 [TBL] [Abstract][Full Text] [Related]